Wave Life Sciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $2,272 | $38,246 | $17,245 | $7,608 |
Gross Profit | 2,272 | 38,246 | 14,983 | 7,608 |
EBITDA | -71,220 | -23,782 | -50,917 | -51,622 |
EBIT | -73,525 | -26,087 | -53,179 | -53,852 |
Net Income | -69,355 | -26,087 | -53,179 | -53,852 |
Net Change In Cash | 2,272 | 38,246 | 17,245 | 7,608 |
Free Cash Flow | -49,221 | -59,991 | -32,113 | -44,914 |
Cash | 368,008 | 544,591 | 602,068 | 196,218 |
Basic Shares | 202,098 | 200,167 | 180,152 | 167,739 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $42,727 | $108,302 | $113,305 | $3,649 |
Gross Profit | 33,875 | 108,302 | 113,305 | 3,649 |
EBITDA | -195,526 | -88,345 | -48,984 | -152,606 |
EBIT | -204,378 | -97,008 | -58,190 | -162,720 |
Net Income | -204,378 | -97,008 | -57,513 | -161,823 |
Net Change In Cash | 42,727 | 108,302 | 113,305 | 3,649 |
Cost of Revenue | -61,848 | |||
Free Cash Flow | -187,493 | -151,964 | -20,546 | -129,142 |
Cash | 602,068 | 302,078 | 200,351 | 88,497 |
Basic Shares | 168,649 | 138,277 | 106,097 | 78,855 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.34 |
2026-03-31 | -$0.13 |
2025-12-31 | -$0.30 |
2025-09-30 | -$0.32 |